Comments
The outlook for the stock of Natco Pharma is bearish. t has been in a strong downtrend since July last year. The price action since August 2020 on the weekly chart indicates a head and shoulder reversal pattern. The sharp 5.5 per cent fall on Tuesday has broken the neckline of this pattern poised at ₹745. It confirms the trend reversal. Also, this fall has taken the stock well below the 200-week moving average which is currently at ₹752. All these strengthens the bearish case. The stock has room to fall further towards ₹600 and even ₹570 over the next one-two months.
The region between ₹745 and ₹752 will act as a strong resistance. Intermediate rallies are likely to be capped at ₹745-₹752. Traders can go short at current levels. Make use of rallies to accumulate shorts at ₹735. Keep the stop-loss at ₹785. Trail the stop-loss down to ₹680 as soon as the stock falls to ₹640. Move the stop-loss further down to ₹625 as soon as the stock touches ₹605 on the downside. Book profits at ₹585. Please note that ₹570 is a strong long-term support. A fresh leg of rally is highly likely from there.
(Note: The recommendations are based on technical analysis. There is risk of loss in trading.)
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.